<DOC>
	<DOCNO>NCT02437175</DOCNO>
	<brief_summary>The primary objective pilot study evaluate efficacy trace element , versus placebo , reduction pain endometriosis American Fertility Society ( AFSr ) score 2 4 , combine adenomyosis , chronic treatment 4 month .</brief_summary>
	<brief_title>Efficacy Trace Elements Treatment Endometriosis : Pilot Study</brief_title>
	<detailed_description>The objective pilot study evaluate efficacy trace element , versus placebo , reduction pain , quality life , use rescue medication ( ibuprofen ) patient endometriosis American Fertility Society ( AFSr ) score 2 4 , combine adenomyosis , chronic treatment 4 month . The safety trace element versus placebo also assess . This prospective , interventional , randomize , placebo-controlled , two parallel-group , double-blind study . Trace elements placebo administer absence treatment add-on treatment common therapy sexual hormone , anti-inflammatory drug surgery . A run-in placebo period 30 day allow eliminate patient respond strongly placebo . The treatment last 4 month . The total duration study 5 month patient . Four medical visit ( Days -45 -30 , 0 , 60 120 ) two phone contact ( Days 30 90 ) schedule . A urine pregnancy test undertaken visit . The quality life scale ( EHP-30 ) fill Days 0 , 60 120 . During whole study period , patient ask fill diary , score pain visual analog scale , blood loss consumption rescue medication ( ibuprofen ) . Phone contact use reinforce compliance collect potential adverse event . Non-serious serious adverse event collect Days 0 120 . All concomitant medication record , include rescue medication Day -45 Day 120 . A paper case report form use . A total 60 patient ( 30 receive trace element 30 receive placebo ) randomize achieve total 50 patient .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<criteria>Written inform consent Woman suffer AFSr 2 4 endometriosis ( combined adenomyosis ) , confirm laparoscopy , laparotomy MRI well biopsy ( do within 3 year inclusion study ) , treat sexual hormone , contraceptive ( stable treatment minimum 2 month ) treatment Time period least 6 month surgical treatment Age 18 45 year Nonmenopausal woman Baseline pain ( Day 45 30 ) least 40 mm visual analog scale No reduction 20 % pain visual analog scale runin placebo period . AFSr 1 endometriosis Adenomyosis without endometriosis Pregnancy Existence another pathology could interfere endometriosis and/or adenomyosis , study followup Psychological psychiatric condition Patient , accord investigator , able comply prerequisite study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>pelvic pain</keyword>
	<keyword>quality life</keyword>
	<keyword>adenomyosis</keyword>
</DOC>